Target intelligence / Profile preview

Blood group RhCE polypeptide (RhCE) (RhCE)

Target
RhCE
Molecular classification
Transmembrane protein, Ammonium transporter family, Blood group antigen
01

Overview

The RhC antigen is a polymorphic protein component of the Rhesus (Rh) blood group system, specifically encoded by the RHCE gene (UniProt P18577). It is a multi-pass transmembrane protein expressed on the surface of erythrocytes, where it forms a complex with other Rh proteins and the Rh-associated glycoprotein (RhAG) to maintain the structural integrity of the red blood cell membrane (NCBI Gene ID: 6006). Beyond its structural role, the RhCE polypeptide is thought to function as an ammonium transporter, contributing to the maintenance of cation gradients (StatPearls: Blood Group Antigens). The RhC antigen is highly immunogenic and is a frequent cause of alloimmunization in Rh-negative individuals following transfusion or pregnancy. This immune response can lead to clinical complications such as hemolytic transfusion reactions and hemolytic disease of the fetus and newborn (HDFN), where maternal anti-C antibodies cross the placenta and destroy fetal red blood cells (PubMed: 25563499). In clinical practice, the RhC antigen is a target for diagnostic antibodies used in blood typing and is managed through the administration of intravenous immunoglobulin (IVIG) or exchange transfusions in cases of severe hemolysis.

Other names
RhC antigenRhesus C antigenRHCERh polypeptide 1RH30ARHCRHERHIXBRHVI
02

Mechanism of action

Binding of specific antibodies to the RhC antigen on red blood cells leads to the clearance of these cells by the reticuloendothelial system, preventing or managing alloimmunization.

03

Biological functions

Erythrocyte membrane integrityAmmonium transportCation transport
04

Disease associations

Hemolytic disease of the fetus and newbornHemolytic transfusion reaction
05

Safety considerations

AlloimmunizationHemolysisDelayed transfusion reaction
06

Interacting drugs

Anti-C immunoglobulin

1 more in the full profile.

07

Biomarkers

RhC phenotypeAnti-C antibody titer

Beyond the preview

Go deeper on Blood group RhCE polypeptide (RhCE) (RhCE).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Blood group RhCE polypeptide (RhCE) (RhCE).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call